Novo Nordisk withdraw insulin Mixtard 30
23 June 2010
Around 90,000 people with diabetes in the UK who use the insulin Mixtard 30 have until 31 December 2010 to change their treatment before the medication is withdrawn by manufacturer Novo Nordisk.
There are several other similar insulin treatments available for people currently prescribed Mixtard 30, and Diabetes UK is advising people affected to consult with their GP, hospital consultant, practice nurse or diabetes specialist nurse to help them decide which option is best for them.
No need to panic
Douglas Smallwood, Diabetes UK Chief Executive, said: “While there is no need to panic, as there is time, it is important for those affected not to wait until December. You will need to see your doctor or nurse as soon as possible to ensure you are changed to an alternative treatment. Both Novo Nordisk and Diabetes UK have notified healthcare professionals of the alternative treatments.
Not in the best interests of people with diabetes
“We are very disappointed about this withdrawal as it is not in the best interests of people with diabetes. We think this is wrong and asked Novo Nordisk to reconsider their decision, considering the 90,000 or so people currently using Mixtard 30, but they argued they are committed to withdrawing all older types of human insulin over time.
“We then asked for a longer withdrawal period to ensure a properly co-ordinated response to this, but that proposal was also turned down.”
Need advice? Call the Novo Nordisk helpline
People with any questions about the withdrawal of Mixtard 30 are asked to call the Novo Nordisk dedicated helpline on 08456 005 055.